Search

Your search keyword '"Ng, Lisa F. P."' showing total 349 results

Search Constraints

Start Over You searched for: Author "Ng, Lisa F. P." Remove constraint Author: "Ng, Lisa F. P." Language english Remove constraint Language: english
349 results on '"Ng, Lisa F. P."'

Search Results

1. Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severity

2. Author Correction: Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave

3. Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2

4. Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave

7. Chikungunya fever

9. Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose

10. Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]

11. Functional and Immunologic Mapping of Domains of the Reticulocyte-Binding Protein Plasmodium vivax PvRBP2a.

12. Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

14. Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells

20. Correction to: Robust Virus‐Specific Adaptive Immunity in COVID‐19 Patients with SARS‐CoV‐2 Δ382 Variant Infection

21. Design and Characterization of a New Formulation for the Delivery of COVID-19-mRNA Vaccine to the Nasal Mucosa.

23. Specific Biomarkers Associated With Neurological Complications and Congenital Central Nervous System Abnormalities From Zika Virus–Infected Patients in Brazil

29. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients

31. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

32. Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation

34. Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis

39. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia

40. Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID‐19) resolves 2 years after infection.

41. Reply to Noret et al

43. Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial.

45. Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections.

47. Discrepant serological findings in SARS‐CoV‐2 PCR‐negative hospitalized patients with fever and acute respiratory symptoms during the pandemic.

49. Viral dynamics and immune correlates of COVID-19 disease severity

Catalog

Books, media, physical & digital resources